Brief: Endra Life Sciences Submits De Novo Request For Its Taeus System Liver Fat Application To FDA
14/08/2023 18:45
Aug 14 (Reuters) - ENDRA Life Sciences Inc NDRA.O :
* ENDRA LIFE SCIENCES SUBMITS DE NOVO REQUEST FOR ITS TAEUS® SYSTEM LIVER
FAT
APPLICATION TO THE U.S. FDA
* ENDRA LIFE SCIENCES INC- ANNOUNCES POSITIVE TOPLINE DATA FROM CLINICAL
STUDIES
COMPARING TAEUS WITH MRI-PDFF
Source text for Eikon: ID:nBw9t9blla
Further company coverage: NDRA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ENDRA Life Sciences
See all newsBrief: ENDRA Life Sciences - Enters First Amendment To Merger Agreement On October 1, 2026 - SEC Filing
ENDRA Life Sciences posts Q2 profit on digital asset gains ahead of merger
Endra Life Sciences Inc Reports Results For The Quarter Ended June 30: Earnings Summary
Endra Life Sciences Inc Expected To Post A Loss Of 84 Cents A Share: Earnings Preview
Brief: ASP Isotopes Announces Proposed Merger Of Noble Africa With Endra Life Sciences